PMC:7199903 / 666-789
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T6 | 94-102 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 22-23 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T8 | 103-108 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T4 | 62-69 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T9 | 70-77 | http://purl.obolibrary.org/obo/BFO_0000019 | denotes | quality |
LitCovid-sample-Enju
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T97 | 0-3 | DT | denotes | The |
| T98 | 4-12 | NN | denotes | analysis |
| T99 | 13-21 | VBZ | denotes | provides |
| T100 | 22-23 | DT | denotes | a |
| T101 | 24-33 | NN | denotes | benchmark |
| T102 | 34-38 | WDT | denotes | that |
| T103 | 39-42 | MD | denotes | can |
| T104 | 43-45 | VB | denotes | be |
| T105 | 46-50 | VBN | denotes | used |
| T106 | 51-53 | TO | denotes | to |
| T107 | 54-61 | VB | denotes | measure |
| T108 | 62-69 | NN | denotes | antigen |
| T109 | 70-77 | NN | denotes | quality |
| T110 | 78-80 | IN | denotes | as |
| T111 | 81-89 | NNS | denotes | vaccines |
| T112 | 90-93 | CC | denotes | and |
| T113 | 94-102 | NN | denotes | antibody |
| T114 | 103-108 | NNS | denotes | tests |
| T115 | 109-112 | VBP | denotes | are |
| T116 | 113-122 | VBN | denotes | developed |
| R100 | T98 | T97 | arg1Of | analysis,The |
| R101 | T98 | T99 | arg1Of | analysis,provides |
| R102 | T101 | T99 | arg2Of | benchmark,provides |
| R103 | T101 | T100 | arg1Of | benchmark,a |
| R104 | T101 | T102 | arg1Of | benchmark,that |
| R105 | T101 | T103 | arg1Of | benchmark,can |
| R106 | T105 | T103 | arg2Of | used,can |
| R107 | T101 | T104 | arg1Of | benchmark,be |
| R108 | T105 | T104 | arg2Of | used,be |
| R109 | T101 | T105 | arg2Of | benchmark,used |
| R110 | T107 | T105 | arg3Of | measure,used |
| R111 | T107 | T106 | arg1Of | measure,to |
| R112 | T101 | T107 | arg1Of | benchmark,measure |
| R113 | T109 | T107 | arg2Of | quality,measure |
| R114 | T109 | T108 | arg1Of | quality,antigen |
| R115 | T107 | T110 | arg1Of | measure,as |
| R116 | T116 | T110 | arg2Of | developed,as |
| R117 | T111 | T112 | arg1Of | vaccines,and |
| R118 | T114 | T112 | arg2Of | tests,and |
| R119 | T114 | T113 | arg1Of | tests,antibody |
| R120 | T112 | T115 | arg1Of | and,are |
| R121 | T116 | T115 | arg2Of | developed,are |
| R122 | T112 | T116 | arg2Of | and,developed |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T6 | 94-102 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 0-123 | Sentence | denotes | The analysis provides a benchmark that can be used to measure antigen quality as vaccines and antibody tests are developed. |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 0-123 | Sentence | denotes | The analysis provides a benchmark that can be used to measure antigen quality as vaccines and antibody tests are developed. |